H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Microbiology D-index 61 Citations 10,328 176 World Ranking 1045 National Ranking 25
Genetics and Molecular Biology D-index 52 Citations 8,075 152 World Ranking 3363 National Ranking 45

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • DNA
  • Genetics

His primary areas of study are Leishmaniasis, Visceral leishmaniasis, Leishmania donovani, Genetics and Immunology. His Leishmaniasis research is multidisciplinary, relying on both Internal medicine, Drug resistance and Leishmania. In the subject of general Leishmania, his work in Amastigote is often linked to Cost effectiveness, thereby combining diverse domains of study.

His Visceral leishmaniasis research is multidisciplinary, incorporating elements of Vector, Incidence, Surgery, Virology and Veterinary medicine. His study in Leishmania donovani is interdisciplinary in nature, drawing from both Transmission, Mortality rate, Gene expression and Typing. The Protozoal disease research he does as part of his general Immunology study is frequently linked to other disciplines of science, such as Acquired immunodeficiency syndrome, therefore creating a link between diverse domains of science.

His most cited work include:

  • Cutaneous leishmaniasis – Authors' reply (361 citations)
  • Evolutionary and geographical history of the Leishmania donovani complex with a revision of current taxonomy (334 citations)
  • Molecular diagnosis of leishmaniasis: current status and future applications. (315 citations)

What are the main themes of his work throughout his whole career to date?

His primary scientific interests are in Leishmaniasis, Leishmania donovani, Leishmania, Genetics and Visceral leishmaniasis. Jean-Claude Dujardin usually deals with Leishmaniasis and limits it to topics linked to Virology and Parasitology. His Leishmania donovani research includes themes of Miltefosine, Amastigote, Drug resistance, Microbiology and Sodium stibogluconate.

His work deals with themes such as Antimonial, Drug development, Drug and Metabolomics, which intersect with Drug resistance. The Leishmania study combines topics in areas such as Kinetoplastida, Aneuploidy, Molecular biology, DNA sequencing and Polymerase chain reaction. His Visceral leishmaniasis study incorporates themes from Veterinary medicine, Epidemiology and Whole genome sequencing.

He most often published in these fields:

  • Leishmaniasis (47.84%)
  • Leishmania donovani (47.84%)
  • Leishmania (43.52%)

What were the highlights of his more recent work (between 2016-2021)?

  • Genetics (42.90%)
  • Leishmania (43.52%)
  • Leishmania donovani (47.84%)

In recent papers he was focusing on the following fields of study:

Jean-Claude Dujardin focuses on Genetics, Leishmania, Leishmania donovani, Visceral leishmaniasis and Drug resistance. As a part of the same scientific family, he mostly works in the field of Leishmania, focusing on DNA sequencing and, on occasion, Ploidy. The various areas that Jean-Claude Dujardin examines in his Leishmania donovani study include Amastigote and Haplotype.

His Visceral leishmaniasis study necessitates a more in-depth grasp of Leishmaniasis. His Leishmaniasis study improves the overall literature in Immunology. His Drug resistance research incorporates elements of Miltefosine and Drug discovery.

Between 2016 and 2021, his most popular works were:

  • Drug resistance and treatment failure in leishmaniasis: A 21st century challenge (259 citations)
  • Modulation of Aneuploidy in Leishmania donovani during Adaptation to Different In Vitro and In Vivo Environments and Its Impact on Gene Expression. (81 citations)
  • Modulation of Aneuploidy in Leishmania donovani during Adaptation to Different In Vitro and In Vivo Environments and Its Impact on Gene Expression. (81 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • DNA
  • Genetics

His primary scientific interests are in Leishmania donovani, Genetics, Visceral leishmaniasis, Leishmaniasis and Gene. His Leishmania donovani study combines topics in areas such as Mutation rate and Haplotype. His work in Genetics covers topics such as Leishmania which are related to areas like Clinical trial.

His biological study spans a wide range of topics, including Metabolome, Virulence, Genotype and Genomics. His Leishmaniasis research is multidisciplinary, incorporating perspectives in Drug resistance and Virology. His studies in Drug resistance integrate themes in fields like Drug development, Computational biology, Immunology and Drug discovery.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Cutaneous leishmaniasis – Authors' reply

Richard Reithinger;Richard Reithinger;Jean-Claude Dujardin;Hechmi Louzir;Claude Pirmez.
Lancet Infectious Diseases (2008)

563 Citations

Evolutionary and geographical history of the Leishmania donovani complex with a revision of current taxonomy

Julius Lukeš;Isabel L. Mauricio;Gabriele Schönian;Jean Claude Dujardin.
Proceedings of the National Academy of Sciences of the United States of America (2007)

495 Citations

Molecular diagnosis of leishmaniasis: current status and future applications.

Richard Reithinger;Richard Reithinger;Richard Reithinger;Jean-Claude Dujardin.
Journal of Clinical Microbiology (2007)

480 Citations

Spread of Vector-borne Diseases and Neglect of Leishmaniasis, Europe

Jean-Claude Dujardin;Lenea Campino;Carmen Cañavate;Jean-Pierre Dedet.
Emerging Infectious Diseases (2008)

452 Citations

Chromosome and gene copy number variation allow major structural change between species and strains of Leishmania

Matthew B. Rogers;James D. Hilley;Nicholas J. Dickens;Jon Wilkes.
Genome Research (2011)

386 Citations

Whole genome sequencing of multiple Leishmania donovani clinical isolates provides insights into population structure and mechanisms of drug resistance

Tim Downing;Hideo Imamura;Saskia Decuypere;Taane G Clark.
Genome Research (2011)

382 Citations

Drug resistance and treatment failure in leishmaniasis: A 21st century challenge

Alicia Ponte-Sucre;Francisco Gamarro;Jean-Claude Dujardin;Michael P. Barrett.
PLOS Neglected Tropical Diseases (2017)

328 Citations

Increasing Failure of Miltefosine in the Treatment of Kala-azar in Nepal and the Potential Role of Parasite Drug Resistance, Reinfection, or Noncompliance

Suman Rijal;Bart Ostyn;Surendra Uranw;Surendra Uranw;Keshav Rai.
Clinical Infectious Diseases (2013)

284 Citations

Influence of Leishmania (Viannia) species on the response to antimonial treatment in patients with American tegumentary leishmaniasis.

Jorge Arevalo;Jorge Arevalo;Luis Ramirez;Vanessa Adaui;Mirko Zimic.
The Journal of Infectious Diseases (2007)

280 Citations

Efficacy of Miltefosine in the Treatment of Visceral Leishmaniasis in India After a Decade of Use

Shyam Sundar;Anup Singh;Madhukar Rai;Vijay K Prajapati.
Clinical Infectious Diseases (2012)

262 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Jean-Claude Dujardin

Shyam Sundar

Shyam Sundar

Banaras Hindu University

Publications: 124

Marleen Boelaert

Marleen Boelaert

Institute of Tropical Medicine Antwerp

Publications: 79

Michael A. Miles

Michael A. Miles

University of London

Publications: 54

Gabriele Schönian

Gabriele Schönian

Charité - University Medicine Berlin

Publications: 52

Yoshihisa Hashiguchi

Yoshihisa Hashiguchi

Kōchi University

Publications: 51

Julius Lukeš

Julius Lukeš

Czech Academy of Sciences

Publications: 42

Mehdi Mohebali

Mehdi Mohebali

Tehran University of Medical Sciences

Publications: 42

Vyacheslav Yurchenko

Vyacheslav Yurchenko

University of Ostrava

Publications: 39

Petr Volf

Petr Volf

Charles University

Publications: 38

Umberto D'Alessandro

Umberto D'Alessandro

University of London

Publications: 35

Marc Ouellette

Marc Ouellette

Université Laval

Publications: 35

Peter J. Myler

Peter J. Myler

Seattle Children's Hospital

Publications: 34

Francine Pratlong

Francine Pratlong

University of Montpellier

Publications: 34

Michel Tibayrenc

Michel Tibayrenc

Centre national de la recherche scientifique, CNRS

Publications: 33

Stephen M. Beverley

Stephen M. Beverley

Washington University in St. Louis

Publications: 32

Philippe Büscher

Philippe Büscher

Institute of Tropical Medicine Antwerp

Publications: 31

Something went wrong. Please try again later.